Biopharmaceutical Third Party Logistics (3PL) Market 2021-26, Share, Growth and Forecast

According to the latest report by IMARC Group, titled, “Biopharmaceutical Third Party Logistics (3PL) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026“, The global biopharmaceutical third party logistics (3PL) market to grow at a CAGR of around 7% during the forecast period (2021-2026).

The distribution of medications utilizing modern vehicles is referred to as biopharmaceutical third-party logistics (3PL). These trucks are specifically intended to automate temperature control and limit the chance of human error while transporting. Biopharmaceutical 3PL assists in the transportation of various medicinal products, the maintenance of inventories, and the fulfillment of orders. It also reduces overhead costs, maintains continuous product supply, and improves an organization’s transportation services.

Market Trends:

One of the primary factors driving the growth of the worldwide biopharmaceutical 3PL market is the increasing requirement for sophisticated logistics solutions to safely move temperature-sensitive pharmaceuticals. Furthermore, the rising trend of medical firms outsourcing logistics to enhance their distribution network is fueling market expansion. As the coronavirus disease (COVID-19) spreads over the world, there is a major increase in demand for 3PL logistics to minimize drug supply disruptions and prioritize the availability of critical care drugs. Furthermore, technical developments and increased environmental concerns among pharmaceutical businesses to lower carbon footprint are producing a positive market outlook.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/biopharmaceutical-third-party-logistics-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Competitive Landscape:

  • Agility Logistics
  • AmerisourceBergen Corporation
  • DB Schenker (Deutsche Bahn)
  • DHL International GmbH (Deutsche Post)
  • FedEx Corporation
  • Kerry Logistics Network Limited
  • Kuehne + Nagel International AG
  • McKesson Corporation
  • SF Express Co. Ltd.
  • United Parcel Service of America Inc.

For more information about this report visit: https://www.imarcgroup.com/biopharmaceutical-third-party-logistics-market

The report has segmented the market on the basis of Product Type, Distribution Channel, Packaging Type and Region.

Breakup by Supply Chain:

  • Cold Chain
  • Non-Cold Chain

Breakup by Service Type:

  • Transportation
    • Air Freight
    • Sea Freight
    • Overland
  • Warehousing and Storage
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About imarcabhay

Check Also

7 Top-Notch EMF Products for a Safer Environment

Highlights Understand EMF Radiation’s two types – extremely low frequency (ELF) and radio frequency (RF). …